Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individualsâ€™ neurobiology to develop personalized and effective treatment options... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANRO is expected to report earnings to rise 7.14% to -60 cents per share on August 19

Alto Neuroscience ANRO Stock Earnings Reports

Q2'25

Est.

$-0.60

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.06

Q2'24

Missed

by $0.07

The last earnings report on May 15 showed earnings per share of -56 cents, beating the estimate of -56 cents. With 260.89K shares outstanding, the current market capitalization sits at 69.58M.

View a ticker or compare two or three

Compare

ANRO